Based on current trial populations and how the FDA has handled semaglutide and tirzepatide approvals, expected eligibility criteria are: BMI 30 , or BMI 27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, OSA) Adults 18 and older Not pregnant or breastfeeding No history of MTC or MEN 2 Retatrutide will almost certainly launch at a high price point estimates suggest $1,200$1,500 per month at list price
Confusing nausea with hunger Mild nausea or stomach discomfort from GLP-1 medication feels similar to hunger pangs
There are some people with diabetes or obesity who can maintain [health gains] with lifestyle
There is no published stability data for the two peptides held together in a single solution over time
Supplementing with bioavailable L-Glutathione may provide the body with the direct biochemical support needed to help manage the chronic oxidative stress associated with Long COVID, ME/CFS, and dysautonomia
Serving Mumbai, Bandra, Khar, Andheri, South Mumbai , and India .